EasyCheck-Femmesafe

EasyCheck-Femmesafe is designed to detect circulating tumor cells (CTCs), which are cancer cells that escape from the tumor and enter the bloodstream. EasyCheck-Femmesafe enriches these CTCs from the blood sample.

Panels covered

This test has been validated only for the detection of Epithelial Breast (adenocarcinoma) and Gynecological malignancies (Ovary, Cervix, and Uterus Endometrium).

What does the report tell me?

The report will tell you if CTCs were detected (indicating a higher risk of the presence of carcinoma) or CTCs were not detected (indicating a lower risk of the presence of carcinoma) in the submitted sample. When Circulating Tumor Cells are detected, the results can indicate the location of the tumor in the body, allowing your healthcare practitioner to advise your next steps.

How to read the report?

For Positive report: Individuals with these findings are advised to consult with their physician for appropriate guidance and additional standard of care workup as may be advised.

For Negative report: EasyCheck test may be repeated annually and the individual is advised to consult a physician if further guidance is required.

Please note: After this screening test, further decisions on patient care and treatment must be based on the independent medical judgment of the treating physicians taking into consideration all available and relevant information concerning the patient's condition, such as personal and family history, physician's examination as well as information from other pertinent diagnostic tests and medical imaging and histopathology.